EA200800260A1 - Способы, композиция и комбинированный продукт для улучшения репродуктивного здоровья у особи мужского пола или улучшения исхода беременности у особи женского пола, сперма (варианты), способ ее получения и животный организм, не принадлежащий к человеческому роду, появившийся в результате оплодотворения указанной спермой - Google Patents

Способы, композиция и комбинированный продукт для улучшения репродуктивного здоровья у особи мужского пола или улучшения исхода беременности у особи женского пола, сперма (варианты), способ ее получения и животный организм, не принадлежащий к человеческому роду, появившийся в результате оплодотворения указанной спермой

Info

Publication number
EA200800260A1
EA200800260A1 EA200800260A EA200800260A EA200800260A1 EA 200800260 A1 EA200800260 A1 EA 200800260A1 EA 200800260 A EA200800260 A EA 200800260A EA 200800260 A EA200800260 A EA 200800260A EA 200800260 A1 EA200800260 A1 EA 200800260A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sperm
female
pregnancy
fertilization
males
Prior art date
Application number
EA200800260A
Other languages
English (en)
Russian (ru)
Inventor
Келтон Пол Тремеллен
Original Assignee
ЭДИЛЕЙД ФЭТИЛИТИ СЭНТЭ ПиТиУай ЭлТиДи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЭДИЛЕЙД ФЭТИЛИТИ СЭНТЭ ПиТиУай ЭлТиДи filed Critical ЭДИЛЕЙД ФЭТИЛИТИ СЭНТЭ ПиТиУай ЭлТиДи
Publication of EA200800260A1 publication Critical patent/EA200800260A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EA200800260A 2005-07-05 2006-07-05 Способы, композиция и комбинированный продукт для улучшения репродуктивного здоровья у особи мужского пола или улучшения исхода беременности у особи женского пола, сперма (варианты), способ ее получения и животный организм, не принадлежащий к человеческому роду, появившийся в результате оплодотворения указанной спермой EA200800260A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69674605P 2005-07-05 2005-07-05
PCT/AU2006/000939 WO2007003007A1 (en) 2005-07-05 2006-07-05 Methods and compositions for improving pregnancy outcome

Publications (1)

Publication Number Publication Date
EA200800260A1 true EA200800260A1 (ru) 2008-06-30

Family

ID=37604041

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800260A EA200800260A1 (ru) 2005-07-05 2006-07-05 Способы, композиция и комбинированный продукт для улучшения репродуктивного здоровья у особи мужского пола или улучшения исхода беременности у особи женского пола, сперма (варианты), способ ее получения и животный организм, не принадлежащий к человеческому роду, появившийся в результате оплодотворения указанной спермой

Country Status (10)

Country Link
US (1) US20090081177A1 (enExample)
EP (1) EP1909911A4 (enExample)
JP (1) JP2008544994A (enExample)
KR (1) KR20080038331A (enExample)
CN (1) CN101282762A (enExample)
AU (3) AU2006265777B2 (enExample)
CA (2) CA2614210A1 (enExample)
EA (1) EA200800260A1 (enExample)
NZ (1) NZ595393A (enExample)
WO (1) WO2007003007A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2641606C2 (ru) * 2012-11-09 2018-01-18 Иасомай АБ N-ацетил-L-цистеин для применения в экстракорпоральном оплодотворении

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT503219B1 (de) * 2006-02-03 2008-07-15 Annerl Brigitte Kombinationspräparat auf basis von antioxidanzien zur verbesserung der samenqualität
US20090143484A1 (en) * 2007-12-03 2009-06-04 Jingang Shi Use of garlic oil to increase bioavailability of coenzyme q-10
US8377454B2 (en) 2009-05-01 2013-02-19 Parviz Gharagozloo Treating male infertility secondary to sperm oxidative stress
CN101879184B (zh) * 2009-05-07 2012-01-18 浙江医药股份有限公司新昌制药厂 用于提高生殖能力的药物组合物及其制备方法和应用
KR101112747B1 (ko) * 2009-07-01 2012-03-13 중앙대학교 산학협력단 동물 정자의 수정능력 예측용 마커
WO2011002251A2 (ko) * 2009-07-01 2011-01-06 중앙대학교 산학협력단 수태능력 예측용 마커
CN101897440B (zh) * 2009-11-23 2012-05-30 北京东方红航天生物技术股份有限公司 辅酶q10复合软胶囊及其制备方法
JP5743444B2 (ja) * 2010-07-08 2015-07-01 学校法人同志社 Ｓ−アリルシステイン又はその塩を有効成分とする精子機能低下抑制剤、又は精子機能改善剤
CN101982094B (zh) * 2010-10-22 2013-05-08 上海交通大学 提高雄性动物精液品质的复合抗氧化剂
JP6074380B2 (ja) * 2014-03-31 2017-02-01 株式会社ダイセル テストステロン産生促進剤
CA2955914C (en) * 2014-07-21 2022-09-06 Ignacio Canals Almazan Tungsten (vi) salts for use thereof in the treatment of infertility, for favoring normal reproduction and fertility in a non-diabetic female mammal, as well as for improving the efficacy of assisted reproductive techniques
JP6416010B2 (ja) * 2015-02-17 2018-10-31 日清ファルマ株式会社 含硫アミノ酸及び亜鉛含有組成物
CN107333704A (zh) * 2016-04-29 2017-11-10 中国农业大学 提高母畜体内早期胚胎附植数量和窝产仔数的方法
IT201600121584A1 (it) * 2016-11-30 2018-05-30 Documedica S A Composizione per il trattamento dell’infertilità maschile
CA3068910A1 (en) 2017-07-17 2019-01-24 Astrazeneca Ab Mpo inhibitors for use in medicine
JP7505691B2 (ja) * 2020-04-14 2024-06-25 学校法人早稲田大学 胚盤胞形成促進剤
JP7645483B2 (ja) * 2020-09-30 2025-03-14 国立大学法人広島大学 エルゴチオネインを含む食品又は飼料
AU2023371556A1 (en) * 2022-11-03 2025-06-12 Exerkine Corporation Fertility enhancement composition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55320B1 (en) * 1983-06-16 1990-08-01 Farley Health Products Infant foods
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5545414A (en) * 1995-03-22 1996-08-13 Abbott Laboratories Cholesterol lowering food product
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5910308A (en) * 1997-03-19 1999-06-08 Sante International Inc. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis
US5883086A (en) * 1997-05-02 1999-03-16 Craft; John C. DHEA-containing nutritional supplement
IL121112A (en) * 1997-06-19 2005-11-20 Lycored Natural Prod Ind Ltd Synergistic pharmaceutical or dietary compositionscomprising lycopene and vitamin e for preventing ldl oxidation
IL123132A (en) * 1998-02-01 2003-10-31 Lycored Natural Prod Ind Ltd Synergistic composition for preventing ldl oxidation and arresting the progression of atherosclerosis, comprising lycopene and garlic
JPH11346712A (ja) * 1998-06-11 1999-12-21 Takehiko Kugo 精子増強食品およびその製造方法
DE19838636A1 (de) * 1998-08-26 2000-03-02 Basf Ag Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6989164B2 (en) * 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US6497885B2 (en) * 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US20050002992A1 (en) * 2003-06-17 2005-01-06 Mccleary Edward Larry Foods, beverages, condiments, spices and salad dressings with specialized supplements
US20030077336A1 (en) * 2001-10-10 2003-04-24 Maf Group, Llc Anti-inflammatory complex containing flaxseed oil
WO2003086080A1 (en) * 2002-04-08 2003-10-23 The Daily Wellnes Company Method and composition for improving fertility health in female and male animals and humans

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2641606C2 (ru) * 2012-11-09 2018-01-18 Иасомай АБ N-ацетил-L-цистеин для применения в экстракорпоральном оплодотворении

Also Published As

Publication number Publication date
AU2008217001A1 (en) 2008-10-16
US20090081177A1 (en) 2009-03-26
CN101282762A (zh) 2008-10-08
AU2006265777A1 (en) 2007-01-11
AU2006265777B2 (en) 2008-06-12
AU2009100215B4 (en) 2009-09-03
NZ595393A (en) 2013-04-26
EP1909911A1 (en) 2008-04-16
EP1909911A4 (en) 2009-08-19
CA2614210A1 (en) 2007-01-11
JP2008544994A (ja) 2008-12-11
KR20080038331A (ko) 2008-05-06
WO2007003007A1 (en) 2007-01-11
AU2009100215A4 (en) 2009-04-23
CA2642008A1 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
Mahmoud et al. Effect of combination of vitamin E and selenium injections on reproductive performance and blood parameters of Ossimi rams
Lieder et al. A two-generation oral gavage reproduction study with potassium perfluorobutanesulfonate (K+ PFBS) in Sprague Dawley rats
MX2009006066A (es) Tratamiento de cerdos con el antigeno pcv.
Mohapatra et al. Effect of supplementation of area specific mineral mixture on reproductive performance of the cows
WO2020013086A1 (ja) 精子の妊孕力増進剤
UA95734C2 (ru) Применение эдта и ее солей для профилактики и лечения бактериальных кишечных заболеваний свиней и усиления эффектов антибиотиков, которые выявляются при подобных заболеваниях
NZ595393A (en) Methods and compositions for improving pregnancy outcome
Emmanuel et al. Epididymal sperm characteristics, testicular morphometric traits and growth parameters of rabbit bucks fed dietary Saccharomyces cerevisiae and/or zinc oxide
Gabr et al. Effect of tonophosphan, zinc oxide, and ascorbic acid on semen, sexual desire, and the fertility rate of Egyptian buffalo bulls
Hilde et al. Going with the herd: same sex interaction and competition in American bison
Guedes et al. Sperm quality of sheep fed cottonseed cake
Aytekin et al. Levels of selected minerals, nitric oxide, and vitamins in aborted Sakis sheep raised under semitropical conditions
CL2009000987A1 (es) Composición de alimentación que comprende peptidoglicano y nucleotidos; y su uso para la profilaxis y/o tratamiento de enfermedades infecciosas en animales.
Kvacheniuk et al. The use of phytotherapy for treatment of thyroid diseases
MXPA06003678A (es) Metodos y estuches para mejorar la capacidad de aprender en un cachorro de perro o cachorro de gato.
El-Kholy et al. Reproductive performance of heat-stressed New Zealand White rabbit bucks in response to different zinc sources
UA43066U (ru) Способ кормления свиноматок в разные периоды формирования плода
Imam et al. Effect of inorganic and organic zinc supplementation on serum testosterone level in murrah buffalo (Bubalus bubalis) bulls
Taghian et al. Semen quality, plasma testosterone, and trace element concentrations in response to dietary supplementation of an organic versus an inorganic source of zinc in Mahabadi bucks.
Schmoelzl et al. The case for pre-parturient selenium and iodine supplementation of ewes for improving lamb survival
WO2010062057A2 (ko) 수정란의 착상 또는 임신 촉진용 조성물
RU2546878C2 (ru) Способ повышения воспроизводительной способности быков-производителей
Ahmed et al. A trial to ameliorate the reproductive performance of native Egyptian cows suffering from reduced fertility
UA35928U (ru) Способ кормления cупоросных свиноматок с использованием сухого лецитина
Sahu et al. Induction of Estrus in Postpartum Anestrus Murrah Buffaloes using Chelated Minerals and Ovsynch Protocol.